Begins Coverage on Forward Pharma A/S (NASDAQ:FWP) assumed coverage on shares of Forward Pharma A/S (NASDAQ:FWPGet Rating) in a research report report published on Monday morning. The brokerage issued a sell rating on the biotechnology company’s stock.

Forward Pharma A/S Price Performance

Shares of FWP stock opened at $3.00 on Monday. The stock’s fifty day moving average price is $3.05 and its two-hundred day moving average price is $3.89. Forward Pharma A/S has a fifty-two week low of $2.81 and a fifty-two week high of $7.20.

About Forward Pharma A/S

(Get Rating)

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Recommended Stories

Receive News & Ratings for Forward Pharma A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forward Pharma A/S and related companies with's FREE daily email newsletter.